IEQ Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.22M | Sell |
16,219
-5,786
| -26% | -$2.58M | 0.04% | 322 |
|
|
2025
Q1 | $10.7M | Buy |
22,005
+3,782
| +21% | +$1.83M | 0.08% | 182 |
|
|
2024
Q4 | $7.34M | Sell |
18,223
-4,358
| -19% | -$1.75M | 0.07% | 188 |
|
|
2024
Q3 | $10.5M | Buy |
22,581
+1,488
| +7% | +$692K | 0.13% | 116 |
|
|
2024
Q2 | $9.89M | Buy |
21,093
+1,877
| +10% | +$880K | 0.13% | 102 |
|
|
2024
Q1 | $8.03M | Buy |
19,216
+1,233
| +7% | +$515K | 0.12% | 118 |
|
|
2023
Q4 | $7.32M | Buy |
17,983
+500
| +3% | +$203K | 0.12% | 117 |
|
|
2023
Q3 | $6.08M | Buy |
17,483
+999
| +6% | +$347K | 0.12% | 114 |
|
|
2023
Q2 | $5.8M | Buy |
16,484
+1,638
| +11% | +$576K | 0.12% | 121 |
|
|
2023
Q1 | $4.68M | Buy |
14,846
+487
| +3% | +$153K | 0.11% | 137 |
|
|
2022
Q4 | $4.15M | Buy |
14,359
+840
| +6% | +$243K | 0.12% | 141 |
|
|
2022
Q3 | $3.91M | Buy |
13,519
+4,875
| +56% | +$1.41M | 0.11% | 141 |
|
|
2022
Q2 | $2.44M | Buy |
8,644
+1,601
| +23% | +$451K | 0.07% | 177 |
|
|
2022
Q1 | $1.84M | Buy |
7,043
+1,199
| +21% | +$313K | 0.04% | 224 |
|
|
2021
Q4 | $1.28M | Buy |
5,844
+2,209
| +61% | +$485K | 0.03% | 262 |
|
|
2021
Q3 | $659K | Buy |
3,635
+1,228
| +51% | +$223K | 0.02% | 365 |
|
|
2021
Q2 | $485K | Sell |
2,407
-102
| -4% | -$20.6K | 0.01% | 371 |
|
|
2021
Q1 | $539K | Buy |
+2,509
| New | +$539K | 0.02% | 271 |
|
|
2020
Q4 | – | Sell |
-2,078
| Closed | -$565K | – | 392 |
|
|
2020
Q3 | $565K | Sell |
2,078
-113
| -5% | -$30.7K | 0.03% | 223 |
|
|
2020
Q2 | $636K | Sell |
2,191
-13
| -0.6% | -$3.77K | 0.04% | 182 |
|
|
2020
Q1 | $524K | Buy |
2,204
+688
| +45% | +$164K | 0.04% | 197 |
|
|
2019
Q4 | $332K | Buy |
+1,516
| New | +$332K | 0.03% | 293 |
|